CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmaron Beijing Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmaron Beijing Co Ltd
No. 6 Taihe Road, Beijing Economic and T
Phone: +86 1057330087p:+86 1057330087 BEIJING, BEJ  100176  China Ticker: 300759300759
Business Summary
Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The Company also operates through the others segment.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer BoliangLou 61 10/27/2016 10/27/2016
President, Chief Operating Officer, Executive Director XiaoqiangLou 56 7/7/2023 10/27/2016
Chief Financial Officer, Secretary of the Board Shing ChungLi 46 10/27/2016 1/1/2015
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Aesica Pharmaceuticals Limited Windmill Industrial Estate Cramlington United Kingdom
TGA Sciences, Inc. 47 Hall Street Medford MA United States
Absorption Systems LP 436 Creamery Way, Suite 600 Exton PA United States

Business Names
Business Name
300759
3759
Absorption Systems LP
Aesica Pharmaceuticals Limited
TGA Sciences, Inc.

General Information
Number of Employees: 21,370 (As of 12/31/2024)
Outstanding Shares: 1,778,195,525 (As of 6/30/2025)
Shareholders: 77,484
Stock Exchange: SHE
Fax Number: +86 1057330087


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!